Skip to content

Drug interactions

Diphenoxylate-atropine + Methscopolamine

Severity: Moderate

Diphenoxylate-atropine and Methscopolamine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both products have antimuscarinic activity, so combined use increases anticholinergic effects such as dry mouth, constipation, urinary retention, blurred vision and tachycardia. Older adults and patients with obstructive conditions are most at risk.

What this interaction means in plain words

Diphenoxylate-atropine and Methscopolamine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Moderate

Why it happens

Additive antagonism at muscarinic receptors.

What to do

Monitor for anticholinergic toxicity, including urinary retention and reduced bowel motility, and reduce doses if symptoms appear. Avoid in patients with glaucoma or intestinal obstruction.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Diphenoxylate-atropine and Methscopolamine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Diphenoxylate-atropine with Methscopolamine?

MediHelp rates the interaction as moderate. Diphenoxylate-atropine and Methscopolamine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both products have antimuscarinic activity, so combined use increases anticholinergic effects such as dry mouth, constipation, urinary retention, blurred vision and tachycardia. Older adults and patients with obstructive conditions are most at risk.

How serious is the interaction between Diphenoxylate-atropine and Methscopolamine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for anticholinergic toxicity, including urinary retention and reduced bowel motility, and reduce doses if symptoms appear. Avoid in patients with glaucoma or intestinal obstruction.

What other medicines interact with Diphenoxylate-atropine?

MediHelp also lists interactions of Diphenoxylate-atropine with, for example, Isocarboxazid, Phenelzine, Tranylcypromine. The full list is on the Diphenoxylate-atropine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in